| __timestamp | Perrigo Company plc | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 18516000 |
| Thursday, January 1, 2015 | 187800000 | 34140000 |
| Friday, January 1, 2016 | 184000000 | 51872000 |
| Sunday, January 1, 2017 | 167700000 | 71772000 |
| Monday, January 1, 2018 | 218600000 | 97501000 |
| Tuesday, January 1, 2019 | 187400000 | 118590000 |
| Wednesday, January 1, 2020 | 177700000 | 169802000 |
| Friday, January 1, 2021 | 122000000 | 192507000 |
| Saturday, January 1, 2022 | 123100000 | 199563000 |
| Sunday, January 1, 2023 | 122500000 | 253598000 |
Cracking the code
In the competitive landscape of pharmaceuticals and biotechnology, strategic investment in research and development (R&D) is crucial. Over the past decade, Perrigo Company plc and Xencor, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Perrigo's R&D expenses have seen a decline of approximately 20%, starting at 15% of their total expenses and dropping to around 12% by 2023. In contrast, Xencor, Inc. has aggressively increased its R&D spending by over 1,200%, reflecting a strategic pivot towards innovation and growth. By 2023, Xencor's R&D expenses accounted for nearly 25% of their total expenses, highlighting their commitment to pioneering new treatments. This divergence in R&D focus underscores the different strategic priorities of these companies, with Xencor betting heavily on future breakthroughs, while Perrigo maintains a more conservative approach.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.